Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion

Internal Medicine

Volumn 36, Issue 8, 1997, Pages 575-578

  Nagai, Takashi ^a   Nagai, Yoko ^a   Tomizawa, Takashi ^a   Mori, Masatomo ^a,b  

^a Public Tomioka General Hospital   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Desensitization; Insulin dependent diabetes mellitus

Indexed keywords

ANTIALLERGIC AGENT; HUMAN INSULIN; IMMUNOGLOBULIN E ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; DESENSITIZATION; ERYTHEMA; FEMALE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INSULIN ALLERGY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; SKIN TEST; SUBCUTANEOUS DRUG ADMINISTRATION; URTICARIA;

EID: 0030866039     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.575     Document Type: Article

References (14)

1. Schernthaner G. Immunogenicity and allergenic potential of animal and human insulins. Diabetes Care 16 Suppl 3: 155, 1993.
2. Robbins DC, Cooper SM, Fineberg SE, Mead PM. Antibodies to covalent aggregates of insulin in blood insulin-using diabetic patients. Diabetes 36: 838, 1987.
3. Patner RE, Phillips TM, Steiner M. Persistent cutaneous insulin allergy resulting from high-molecular-weighl insulin aggregates. Diabetes 39: 728, 1990.
4. Home PD, Capaldo B, Burrin JM, Worth R, Alberti KG. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: Improved control with CSII. Diabetes Care 5: 466, 1982.
5. The Kroc Collaborative Study Group: Diabetic retinopathy after two years of intensified insulin treatment. Follow-up of the Kroc Collaborative Study. JAMA 260: 37, 1988.
6. Fireman P, Fineberg SE, Galloway JA. Development of IgE antibodies to human (recombinant DNA), porcine and bovine insulins in diabetic subjects. Diabetes Care 5 Suppl 2: 119, 1982.
7. Yamagishi S, Abe T, Sawada T. A case of newly diagnosed non-insulindependent diabetes associated with immediate-type allergy against human insulin. Horm Res 43: 300, 1995.
8. deShazo RD, Mather P, Grant W, et al. Evaluation of patients with local reactions to insulin with skin tests and in vitro techniques. Diabetes Care 10: 3.10, 1987.
9. Patterson R, Lucena G, Metz R, Roberts M. Reaginic antibody against insulin: demonstration of antigenic distinction between native and extracted insulin. J Immunol 103: 1061, 1969.
10. Palmer JP, Asplin CM,Clemons P, et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337, 1983.
11. AalberseRC, van der Gaag R, van Leeuwen J. Serologic aspects of lgG4 antibodies. 1. Prolonged immunization results in an IgG4-restricted response. J Immunol 130: 722, 1983.
12. Grammer LC, Roberts M, Buchanan TA, Fitzsimons R, Metzger BE, Patterson R. Specificity of immunoglobulin E and immunoglobulin G against human (recombinant DNA) insulin in human insulin allergy and resistance. J Lab Clin Med 109: 141, 1987.
13. Lichtenstein LM, Ishizaka K, Norman PS, Sobotka AK, Hill BM IgE antibody measurement in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. J Clin Invest 52: 472, 1973.
14. Falholt K. Determination of insulin specific IgE in serum of diabetic patients by solid-phase radioimmunoassay. Diabetologia 22: 254, 1982.